Merck & Co. ( MRK ) recently presented new data on its insomnia candidate, suvorexant, at the 21st Congress of the European Sleep Research Society (ESRS). Data from a 2-month
Read the article:
New Data on Merck’s Insomnia Drug – Analyst Blog
Merck & Co. ( MRK ) recently presented new data on its insomnia candidate, suvorexant, at the 21st Congress of the European Sleep Research Society (ESRS). Data from a 2-month
Read the article:
New Data on Merck’s Insomnia Drug – Analyst Blog